
During a live event, Rushang Patel, MD, PhD, and participants discussed referral timing, bridging, and payer barriers that shape access to cellular therapy in early relapsed multiple myeloma.
Outcomes in Newly Diagnosed Transplant-Ineligible Multiple Myeloma
Case: 83-Year-Old Man With NDMM Ineligible for Transplant
History and Presentation:
Diagnostic Workup:
Treatment:
Patient was started on D-Rd